Molnlycke to Co-promote Endoform In the US
Filed with ASX · · 2 pages · English
Earlier from Aroa Biosurgery
- Notification of cessation of securities - ARX
- Investor Presentation - Symphony RCT
- Invite to Investor Webinar on Symphony RCT
- Investor Presentation - MASTRR Interim Analysis
- Change in substantial holding
Later from Aroa Biosurgery
- Change in substantial shareholding for ARX
- AROA Appoints Mark Dunwoodie as CFO
- Aroa Biosurgery H1 FY27 Results & Investor Event
Follow Aroa Biosurgery into a list and get an email when it puts out news.
Follow Aroa Biosurgery